Tactile Systems Technology (NASDAQ:TCMD – Get Free Report) was upgraded by stock analysts at StockNews.com from a “buy” rating to a “strong-buy” rating in a research report issued on Wednesday.
A number of other analysts also recently issued reports on TCMD. Oppenheimer downgraded Tactile Systems Technology from an “outperform” rating to a “market perform” rating in a research report on Tuesday, November 5th. B. Riley assumed coverage on shares of Tactile Systems Technology in a report on Thursday, September 26th. They issued a “buy” rating and a $23.00 target price for the company. Finally, BTIG Research downgraded shares of Tactile Systems Technology from a “buy” rating to a “neutral” rating in a report on Tuesday, November 5th.
Check Out Our Latest Analysis on Tactile Systems Technology
Tactile Systems Technology Trading Up 0.4 %
Hedge Funds Weigh In On Tactile Systems Technology
Several hedge funds have recently bought and sold shares of TCMD. Bank of New York Mellon Corp grew its holdings in shares of Tactile Systems Technology by 14.6% in the second quarter. Bank of New York Mellon Corp now owns 182,752 shares of the company’s stock worth $2,182,000 after purchasing an additional 23,296 shares during the last quarter. Rhumbline Advisers grew its stake in Tactile Systems Technology by 11.6% in the 2nd quarter. Rhumbline Advisers now owns 39,318 shares of the company’s stock worth $469,000 after acquiring an additional 4,099 shares in the last quarter. Los Angeles Capital Management LLC purchased a new position in shares of Tactile Systems Technology during the second quarter worth approximately $1,187,000. Acadian Asset Management LLC raised its stake in shares of Tactile Systems Technology by 31.5% during the second quarter. Acadian Asset Management LLC now owns 157,925 shares of the company’s stock valued at $1,884,000 after acquiring an additional 37,813 shares in the last quarter. Finally, Quest Partners LLC purchased a new stake in shares of Tactile Systems Technology in the second quarter valued at approximately $224,000. Institutional investors own 83.43% of the company’s stock.
About Tactile Systems Technology
Tactile Systems Technology, Inc, a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers.
Featured Articles
- Five stocks we like better than Tactile Systems Technology
- What Are the U.K. Market Holidays? How to Invest and Trade
- MercadoLibre: Latin America’s Digital Titan Just Got Cheaper
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Breaking Down Pegasystems, A Wedbush Top AI Pick for 2025
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Shutterstock and Getty: A $3.7 Billion Visual Content Giant
Receive News & Ratings for Tactile Systems Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tactile Systems Technology and related companies with MarketBeat.com's FREE daily email newsletter.